EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:)

Dumitru Emanuel Dogaru iD, Serban Rosu iD, Dionisio Franco Barattini iD, Simone Guadagna iD, Luca Barattini iD, Bogdan Andor iD

JMIR Research Protocols · 2024

DOI: 10.2196/13642 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2024. Verfasst von Dumitru Emanuel Dogaru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics - Traumatology, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Feasibility Studies, Hyaluronic Acid. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoarthritis (OA) is a disabling condition that affects more than one-third of people older than 65 years. Currently, 80% of these patients report movement limitations, 20% are unable to perform major activities of daily living, and approximately 11% require personal care. In 2014, the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) recommended, as the first step in the pharmacological treatment of knee osteoarthritis, a background therapy with chronic symptomatic slow-acting osteoarthritic drugs such as glucosamine sulfate, chondroitin sulfate, and hyaluronic acid. The latter has been extensively evaluated in clinical trials as intra-articular and oral administration. Recent reviews have shown that studies on oral hyaluronic acid generally measure symptoms using only subjective parameters, such as visual analog scales or quality of life questionnaires. As a result, objective measures are lacking, and data validity is generally impaired.

Objective

The main goal of this pilot study with oral hyaluronic acid is to evaluate the feasibility of using objective tools as outcomes to evaluate improvements in knee mobility. We propose ultrasound and range of motion measurements with a goniometer that could objectively correlate changes in joint mobility with pain reduction, as assessed by the visual analog scale. The secondary objective is to collect data to estimate the time and budget for the main double-blind study randomized trial. These data may be quantitative (such as enrollment rate per month, number of screening failures, and new potential outcomes) and qualitative (such as site logistical issues, patient reluctance to enroll, and interpersonal difficulties for investigators).

Methods

This open-label pilot and feasibility study is conducted in an orthopedic clinic (Timisoara, Romania). The study includes male and female participants, aged 50-70 years, who have been diagnosed with symptomatic knee OA and have experienced mild joint discomfort for at least 6 months. Eight patients must be enrolled and treated with Syalox 300 Plus (River Pharma) for 8 weeks. It is a dietary supplement containing high-molecular-weight hyaluronic acid, which has already been marketed in several European countries. Assessments are made at the baseline and final visits.

Results

Recruitment and treatment of the 8 patients began on February 15, 2018, and was completed on May 25, 2018. Data analysis was planned to be completed by the end of 2018. The study was funded in February 2019. We expect the results to be published in a peer-reviewed clinical journal in the last quarter of 2024.

Conclusions

The data from this pilot study will be used to assess the feasibility of a future randomized clinical trial in OA. In particular, the planned outcomes (eg, ultrasound and range of motion), safety, and quantitative and qualitative data must be evaluated to estimate in advance the time and budget required for the future main study. Finally, the pilot study should provide preliminary information on the efficacy of the investigational product. Trial Registration ClinicalTrials.gov NCT03421054; https://clinicaltrials.gov/study/NCT03421054 International Registered Report Identifier (IRRID) RR1-10.2196/13642

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoarthritis, KneeFeasibility StudiesHyaluronic AcidHumansPilot ProjectsMaleFemaleAgedMiddle AgedQuality of LifeEndpoint Determination

Stichwörter der Autor:innen

feasibility studyhyaluronic acidkneeknee osteoarthritisosteoarthritisoutcome assessmentpainpilot trialultrasonography

Substanzen

Hyaluronic Acid

Autor:innen und Institutionen

  • Department of Orthopaedics - Traumatology, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania.
  • Clinical Research, Oral and Maxillofacial Surgery, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania.
  • Opera CRO, a TIGERMED company, Timisoara, Romania.
  • TIGERMED Italy, Genova, Italy.
  • Profesor Universitar Doctor Teodor Șora Research Centre, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania.

ORCID-Profile: Dumitru Emanuel Dogaru, Serban Rosu, Dionisio Franco Barattini, Simone Guadagna, Luca Barattini, Bogdan Andor

Zitieren

APA

Dogaru, D. E., Rosu, S., Barattini, D. F., Guadagna, S., Barattini, L., & Andor, B. (2024). Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:). JMIR Research Protocols. https://doi.org/10.2196/13642

Vancouver

Dogaru DE, Rosu S, Barattini DF, Guadagna S, Barattini L, Andor B. Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:). JMIR Research Protocols. 2024. doi:10.2196/13642

BibTeX
@article{Dogaru2024,
  author = {Dogaru, Dumitru Emanuel and Rosu, Serban and Barattini, Dionisio Franco and Guadagna, Simone and Barattini, Luca and Andor, Bogdan},
  title = {Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:)},
  journal = {JMIR Research Protocols},
  year = {2024},
  doi = {10.2196/13642}
}
Kostenlos starten →